Patents by Inventor Eric Tsao

Eric Tsao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody specific to alpha-toxin of and uses thereof
    Patent number: 11530256
    Abstract: The present disclosure relates to an antibody or antigen-binding fragment thereof that specifically bind to ?-toxin of Staphylococcal aureus. The present disclosure also relates to a pharmaceutical composition, a method for treating and/or preventing diseases and/or disorders caused by Staphylococcal aureus infection in a subject in need, and a method for detecting ?-toxin of Staphylococcal aureus in a sample.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: December 20, 2022
    Assignee: SYNERMORE BIOLOGICS (SUZHOU) CO., LTD.
    Inventors: Tzu-Yuan Chao, Ching-Wen Chang, Eric Tsao
  • ANTIBODY SPECIFIC TO ALPHA-TOXIN OF STAPHYLOCOCCAL AUREUS AND USES THEREOF
    Publication number: 20210317193
    Abstract: The present disclosure relates to an antibody or antigen-binding fragment thereof that specifically bind to ?-toxin of Staphylococcal aureus. The present disclosure also relates to a pharmaceutical composition, a method for treating and/or preventing diseases and/or disorders caused by Staphylococcal aureus infection in a subject in need, and a method for detecting ?-toxin of Staphylococcal aureus in a sample.
    Type: Application
    Filed: March 24, 2021
    Publication date: October 14, 2021
    Inventors: Tzu-Yuan CHAO, Ching-Wen CHANG, Eric TSAO
  • Anti-EGFR antibody and uses of same
    Patent number: 10759860
    Abstract: This disclosure relates generally to an EGFR antibody and its therapeutic effects on tumor inhibition in vitro and in vivo, alone or in combination with various chemotherapeutic agents. In particular, the present disclosure relates to methods for the treatment of cancer, comprising administering an EGFR antibody, alone or in combination with a chemotherapeutic agent.
    Type: Grant
    Filed: September 15, 2015
    Date of Patent: September 1, 2020
    Assignee: Synermore Biologics Co., Ltd.
    Inventor: Eric Tsao
  • ANTI-EGFR ANTIBODY AND USES OF SAME
    Publication number: 20170267765
    Abstract: This disclosure relates generally to an EGFR antibody and its therapeutic effects on tumor inhibition in vitro and in vivo, alone or in combination with various chemotherapeutic agents. In particular, the present disclosure relates to methods for the treatment of cancer, comprising administering an EGFR antibody, alone or in combination with a chemotherapeutic agent.
    Type: Application
    Filed: September 15, 2015
    Publication date: September 21, 2017
    Inventor: Eric TSAO
  • Methods of Producing Influenza Vaccine Compositions
    Publication number: 20090246225
    Abstract: Methods and compositions for the optimization of production of influenza viruses suitable as influenza vaccines are provided.
    Type: Application
    Filed: December 8, 2008
    Publication date: October 1, 2009
    Applicant: MedImmune, LLC
    Inventors: George Robert Trager, George Kemble, Richard M. Schwartz, Harshvardhan Mehta, Vu Truong-Le, Zhongying Chen, Alfred A. Pan, Eric Tsao, Chiaoyin Kathy Wang, Luisa Yee, Palani Balu
  • Methods of Producing Influenza Vaccine Compositions
    Publication number: 20070161085
    Abstract: Methods and compositions for the optimization of production of influenza viruses suitable as influenza vaccines are provided.
    Type: Application
    Filed: January 30, 2007
    Publication date: July 12, 2007
    Applicant: Medlmmune Vaccines, Inc.
    Inventors: George Trager, George Kemble, Richard Schwartz, Harshvardhan Mehta, Vu Truong-Le, Zhongying Chen, Alfred Pan, Eric Tsao, Chiaoyin Wang, Luisa Yee, Palani Balu
  • Methods of producing influenza vaccine compositions
    Publication number: 20040265987
    Abstract: Methods and compositions for the optimization of production of influenza viruses suitable as influenza vaccines are provided.
    Type: Application
    Filed: February 25, 2004
    Publication date: December 30, 2004
    Applicant: Medlmmune Vaccines, Inc.
    Inventors: George Robert Trager, George Kemble, Richard M. Schwartz, Harshvardhan Mehta, Vu Truong-Le, Zhongying Chen, Alfred A. Pan, Eric Tsao, Chiaoyin Kathy Wang, Luisa Yee, Palani Balu